AMW is an innovative specialty pharmaceutical company, which initially starting 2008 life as a CDMO, now develops and markets own proprietary bio-degradable sustained-release drug delivery systems and out-licenses these to international pharmaceutical companies. Products developed by AMW enable the administration of drugs via implants (subcutaneous). We have apart from a Leuprorelide implant the only international available generic of Goserelin implants.